Cairo University

TUESDAY, Oct. 1, 2024 -- Children with primary nocturnal enuresis may have vitamin D insufficiency and deficiency as well as vitamin B 12 deficiency, according to a study published online June 10 in Annals of Medicine . Hoda Atef Abdelsattar Ibrahim, from Cairo University, and colleagues examined the prevalence of vitamin D and vitamin B 12 deficiencies in enuretic children. The analysis included 288 children seen at an outpatient clinic for nocturnal enuresis. The researchers found that vitamin D insufficiency predominated (48.3 percent), while vitamin D deficiency was present in 31.3 percent. Vitamin B 12 deficiency was seen in 25 percent of children. There was a stronger inverse correlation between vitamin D and the number of enuresis episodes per day than vitamin B 12 . A cutoff of 13.7 ng/mL for vitamin D was identified, below which failure to have dry nights was predicted. Protective factors for the absence of dry nights were higher vitamin D levels and behavioral treatment coexistence. "Vitamin D insufficiency may be the most prevalent vitamin D abnormality in children with primary nocturnal enuresis. Vitamin D insufficiency may be more common in children with severe enuresis than vitamin B 12 deficiency," the authors write. "This study may invite further research to examine the possible use of vitamin D and vitamin B 12 as potential adjuvant therapies for children with primary nocturnal enuresis." Abstract/Full Text Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

DUBLIN, May 22, 2023 /PRNewswire/ -- The "Medical Device Regulations in the Middle East and North Africa Training Course" conference has been added to ResearchAndMarkets.com's offering. The size of the medical device market in the Middle East has expanded over recent years and this trend is forecast to continue. The growth is due in part to innovations in technology as the majority of Middle Eastern countries are early adopters of technological advancement, which provides opportunities for medical device companies. The regulatory environment in the region is also developing and this annual seminar will provide an essential overview of the key requirements for product approvals for medical devices in the Middle East and North Africa. The programme will focus on the regulatory requirements and developments in individual countries and include interactive discussion sessions to allow you to exchange experiences with our expert faculty and other delegates. Benefits of attending: Gain a valuable introduction to the medical device markets: countries, numbers, economical facts and trends, regulatory environment Familiarise yourself with medical device regulations in the countries of the Middle East and North Africa Understand medical devices and their classification Clarify procedures for company and product registration Discuss recent developments in the region Meet, network and share experiences with other industry colleagues Key Topics Covered: The medical device markets in the Middle East and North Africa (MENA) Markets and Culture Healthcare Business culture Economic overview Regulatory environment and characteristics General regulatory requirements Company and product registration Key documents needed Basic structure of a dossier Regulatory summary Medical Devices and their classification What is a medical device Different classes of products Individual Country Presentations: Algeria, Bahrain, Egypt, Israel, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Palestine, Saudi Arabia, Sudan, Syria, Tunisia, UAE and Yemen Recent Developments in the Region Harmonisation activities Countries with new regulatory requirements for medical devices Countries in the process of establishing regulatory guidance for obtaining marketing authorisations Discussion sessions will take place throughout the two days Speakers: Heba Hashem Middle East and Africa Associate Director PPD Heba has been working with Regulatory Affairs in the Middle East for more than 25 years. She has a Pharmaceutical and Business background being a graduate of the Faculty of Pharmacy (Cairo University), RAC certified in addition to an MBA at Maastricht School of Business. For the past 20 years Heba held the position of Middle East & Africa Regulatory and Quality Head at different Pharmaceutical and Medical Device companies; Gambro, Bayer and Novo Nordisk. Heba is now the Middle East and Africa Associate Director at PPD where she is providing regulatory consulting services and training to Health Care companies. Ilona Putz Founder PULONA Ilona Putz founded PULONA Emerging Markets based in the UAE which is dedicated to creating and developing tailor-made business concepts for clients in the healthcare sector across the Middle East. She has worked in the pharmaceutical industry since 1988 for companies like MSD, SmithKline Beecham, Karl Engelhard and HEXAL where she has held the position of Regulatory Affairs Regional Manager, responsible for regulatory affairs and later on in commercial operations for countries in the Middle East and Africa. Between 2005 and August 2008 she was Regional Head, Middle East, for Sandoz International, Germany, responsible for all commercial and business development activities. She consults also for RegAff for the Middle East which is the only Global Specialist Regulatory Affairs company with a broad geographical coverage, and for Emergo Group, which is a global consultancy company for Medical Devices. She spoke also for DIA (Drug Information Association) Switzerland on "Clinical Trials in the Middle East", DIA Europe Meeting, Geneva 2011. For more information about this conference visit About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Logo: SOURCE Research and Markets

LOS ANGELES--( BUSINESS WIRE )--The bioscience community in Los Angeles is deeply saddened by the passing of Ahmed Enany, Founder, President and CEO of the Southern California Biomedical Council (SoCalBio), on March 22, 2023 following a recent illness. He was 68 years old. Mr. Enany created SoCalBio in 1995 as part of the Rebuild LA initiative following the 1992 civil unrest in Los Angeles. Over the years, he built it into one of the nation's largest member-supported associations serving the bioscience, medical device and digital health industries. SoCalBio currently has more than 450 corporate and institutional members across the Greater Los Angeles region. “The board of SoCalBio is deeply saddened by the loss of the incredible human being who was Ahmed Enany,” said Robert Greenberg, MD, PhD, Chairman of SoCalBio. “We can’t imagine a world without him, but we are equally determined to carry forth his legacy and expand on the platform he built.” For nearly three decades, SoCalBio has been instrumental in helping emerging firms gain access to capital, potential partners and business support services while promoting technology transfer and workforce training/job creation. SoCalBio’s marquee events, including the annual Investor & Partnership Conference and the Digital Health Conference, are leading platforms for biomed start-ups to tap new funding sources. Mr. Enany’s vision and tireless efforts played a vital role in helping build the life science industry in Southern California. His prodigious networking and interpersonal skills brought together thousands of people and helped launch countless ventures. Industry insiders knew him as L.A.’s “Mr. Biotech.” Those who knew him well also cherished Ahmed as a mentor, advocate, philosopher and friend. "No one contributed more or worked harder than Ahmed Enany to build and strengthen the life sciences ecosystem in the greater Los Angeles region,” added Jonathan G. Lasch, PhD, Vice Chairman of SoCalBio. “Whether it was researchers, managers, service providers, investors or politicians, Ahmed knew them all and joyfully built a network across all shapes and sizes of companies and academic institutions. He connected all of us in a meaningful and powerful way, helping everyone who sought his support. His talent and zeal were unique and we will sorely miss him." A native of Egypt, Mr. Enany graduated at the top of his class with a degree in political science from Cairo University before coming to the United States in 1978 to attend UCLA, where he studied political science, urban planning and regional economic development. Mr. Enany served as a board member of the California Technology Council (a strategic partner of the UCLA Business of Science Center) and as an advisory member at several institutions of higher learning, including Santiago Canyon College and Cal Poly Pomona. He was currently teaching a bioengineering course (“MedTech Innovation: Entrepreneurial Opportunities in Medical Technology”) at UCLA focused on preparing students for careers in healthcare, product development and entrepreneurship. Mr. Enany’s kindness and generosity were boundless and well-known. He will be sorely missed but leaves behind a rich legacy of helping make the Los Angeles region a center for bioscience innovation. A memorial is planned (date to be announced) at the Athenaeum on the California Institute of Technology campus. About SoCalBio: SoCalBio is a nonprofit, member-supported trade association that promotes bioscience research, development, manufacturing, job creation and overall economic growth in the Greater Los Angeles region. The Council’s programs help local firms access capital, potential partners, and business support services. The annual SoCalBio Conference has grown to become the region’s premier showcase for emerging life-science companies and technologies. SoCalBio also promotes technology transfer and workforce training while informing policymakers and the public at large about the benefits of the region’s life-science industry. More information about SoCalBio is available at www.socalbio.org .